Gsk
Clinical Biomarker Lead, Clinical Pharmacology and Experimental Medicine
Gsk
Investigator-Neurodegeneration, Als Group, Neuroscience Dpu
Gsk Sep 2016 - Nov 2017
Investigator-Translational Science, Dermatology Unit, Iitau
University of Pennsylvania Oct 2013 - Sep 2016
Research Associate
University of Pennsylvania May 2010 - Sep 2013
Postdoctoral Researcher
Education:
University of Pennsylvania 2003 - 2010
Doctorates, Doctor of Philosophy, Pharmacology
Bucknell University 1999 - 2003
Bachelors, Bachelor of Science, Chemical Engineering
Skills:
In Vitro Biochemistry Molecular Biology In Vivo Cell Culture Pcr Rnaseq Rna Isolation Translational Research Single Cell Analysis Disease Signatures Immunohistochemistry Pharmacology Confocal Microscopy Biomarkers Immunocytochemistry Western Blotting Animal Models Calcium Imaging Molecular Pharmacology Arna Amplification Acute Brain Slice Mitochondrial Membrane Voltage Single Cell Sequencing Neuroscience
EMD Chemicals since Nov 2002
Marketing Manager
Microbiology International Sep 2001 - Sep 2002
Technical Support
Chemunex Inc (North American affiliate of Chemunex SA) 1999 - 2001
Technical Support Liason
Education:
University of Miami 1995 - 1998
BS, Microbiology and Immunology
Skills:
Cross Functional Team Leadership Marketing Pharmaceutical Industry Lifesciences Biotechnology Product Development Product Launch Competitive Analysis Sap Vendor Management Microbiology Product Management Strategy Marketing Strategy Food Microbiology Project Management Influence Without Authority Positive Team Player Persuasive Writing Market Analysis Process Improvement Management Life Sciences Business Process Improvement
- Philadelphia PA, US Ivan J. Dmochowski - Philadelphia PA, US Sean B. Yeldell - Philadelphia PA, US Julianne C. Griepenburg - Philadelphia PA, US Teresa L. Rapp - Philadelphia PA, US Jennifer M. Singh - Havertown PA, US Jaehee Lee - Wynnewood PA, US
Compositions and methods of capturing one or more nucleic acid molecules of a cell or subcellular compartment are described. In certain aspects, the compositions comprise a caged molecule comprising one or more photolinkers and an antisense oligonucleotide, which when uncaged hybridizes to a target nucleic acid molecule.